The Fund seeks to replicate (with a maximum tracking error of 1%) the performance of the ECPI Global ESG Medical Tech (NR) Index (the Index) by investing in the shares issued by companies included in the Index, respecting the Index's weightings (full replication), or in a sample of securities included in the Index (optimised replication), or by investing in a substitute basket, composed of, inter alia, shares of companies, debt securities or cash (synthetic replication). When investing in a basket of securities called substitute basket, the performance is swapped with the performance of the index, generating counterparty risk.